학술논문
NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromes.
Document Type
Article
Author
Source
Subject
*MYELODYSPLASTIC syndromes
*BONE marrow diseases
*
Language
ISSN
0887-6924
Abstract
A letter to the editor is presented in response to the article related to myelodysplastic syndromes (MDS) in the May 27, 2013 issue.